Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$1.5 - $3.41 $10,986 - $24,974
-7,324 Reduced 38.24%
11,831 $29,000
Q4 2023

Feb 14, 2024

BUY
$1.82 - $3.16 $34,862 - $60,529
19,155 New
19,155 $45,000
Q2 2023

Jul 10, 2023

SELL
$7.35 - $13.21 $22,270 - $40,026
-3,030 Reduced 7.14%
39,413 $289,000
Q1 2023

Apr 14, 2023

BUY
$7.79 - $16.29 $330,630 - $691,396
42,443 New
42,443 $439,000

Others Institutions Holding EBS

About Emergent BioSolutions Inc.


  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $420M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Ae Wealth Management LLC Portfolio

Follow Ae Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ae Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ae Wealth Management LLC with notifications on news.